Related Experiment Videos
Cardiogenic cerebral emboli: diagnosis and treatment
1Neurology Unit, Hasharon Hospital, Golda Medical Center, Petah-Tiqva, Tel Aviv, Israel.
Insights
New imaging technologies improve detection of heart-related stroke causes. Treatment guidelines for stroke prevention and heart attack recovery are evolving, with warfarin and aspirin playing key roles.
Area of Science:
- Cardiology
- Neurology
- Medical Imaging
Background:
- Advancements in imaging technology enhance the identification of cardiogenic cerebral emboli.
- Echocardiography, particularly transesophageal echocardiography, is the gold standard for detecting cardiac sources of emboli.
- Transcranial Doppler ultrasound is crucial for identifying cerebral emboli.
Purpose of the Study:
- To review current diagnostic capabilities for cardiogenic cerebral emboli.
- To discuss evolving treatment strategies for stroke prevention and management.
- To highlight the roles of warfarin and aspirin in various cardiovascular conditions.
Main Methods:
- Review of recent technological advancements in echocardiography and transcranial Doppler.
- Analysis of data from large randomized trials on stroke prevention and myocardial infarction treatment.
- Evaluation of established and emerging pharmacological interventions.
Main Results:
- Warfarin is indicated for primary stroke prevention in elderly patients with nonvalvular atrial fibrillation.
- Aspirin may suffice for primary stroke prevention in specific younger patient groups without risk factors.
- Warfarin demonstrates superiority in treating myocardial infarction survivors with left ventricular thrombi and patients with mechanical prosthetic valves.
Conclusions:
- Improved diagnostic tools facilitate earlier and more accurate identification of stroke etiology.
- Treatment strategies for stroke and myocardial infarction are becoming more refined.
- Pharmacological management, including warfarin and aspirin, is critical but requires careful consideration of patient-specific factors and risks.
Abstract:
New technology has made it possible to identify cardiogenic cerebral emboli more easily and reliably. In recent years echocardiography, and in particular transesophageal echocardiography, has become the gold standard for the identification of cardiogenic sources of emboli, whereas transcranial Doppler is an important technique for the detection of cerebral emboli. Treatment strategies are better established and more accurate, if more complex, since the completion of large randomized trials. For primary prevention of stroke in elderly patients with nonvalvular atrial fibrillation, warfarin is generally indicated, yet in patients aged 60-75 years with no risk factors, aspirin may be sufficient. Warfarin is hazardous in older high-risk patients even at the 'low intensity' of the anticoagulation regimen; even lower doses are therefore being tested. Heparin and aspirin are indicated for short-term treatment of acute myocardial infarction, whereas for long-term treatment aspirin is still the drug of choice. However, if mobile left ventricular thrombi are present, warfarin is superior and new studies have shown its effectiveness for all myocardial infarction survivors. Combined treatment of warfarin and aspirin appears to be most effective in patients with mechanical prosthetic valves.